Revive Therapeutics Ltd (RVVTF)

[ReikoBlack]

In today's PR the Company announced that "There are currently nine clinical sites participating in the Study with an additional six more clinical sites joining the Study in January to satisfy the overall enrollment goal of up to 1,000 patients".

Question seeking opinion(s): Are these other additional clinical sites going to be located in the USA or could they be located in Canada?

The reason i'm asking is in the December 2nd Company PR it was announced that Dr. Joel Moody was appointed "as a medical and clinical advisor to the Company to assist in the expansion of clinical studies in Canada and the clinical data analysis on the ongoing U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild-moderate COVID-19".